Structure Therapeutics Inc.
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| – | +187.2% | -12.0% | +392.6% | +87.4% | +75.3% | |
| – | +184.4% | -14.8% | +408.8% | +88.2% | +76.2% | |
| – | +544.0% | -75.2% | +397.5% | +30.6% | +371.7% | |
| – | +186.6% | -15.3% | +414.4% | +89.1% | +63.7% | |
| – | +547.7% | -27.9% | – | – | – | |
| – | +187.5% | +21.1% | -86.4% | +32.5% | +75.5% | |
| – | +184.9% | +50.3% | +90.2% | +45.6% | +75.7% | |
| – | +137.4% | -25.5% | +453.8% | +17.9% | +69.5% | |
| – | +128.2% | +72.5% | -21.1% | +69.2% | +72.8% | |
| – | – | – | – | +90.9% | +75.3% | |
| – | – | – | – | – | – | |
| – | +0.0% | +0.0% | +0.4% | +43.3% | +12.5% |
Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.